These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1328 related articles for article (PubMed ID: 28058848)

  • 61. Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation.
    Healy CA; Carrillo RG
    Heart Rhythm; 2015 Jul; 12(7):1565-73. PubMed ID: 25839113
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Elevated B-type natriuretic peptide is associated with increased in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator implantation.
    Wei S; Loyo-Berríos NI; Haigney MC; Cheng H; Pinnow EE; Mitchell KR; Beachy JH; Woodward AM; Wang Y; Curtis JP; Marinac-Dabic D
    Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):346-54. PubMed ID: 21487093
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of the wearable cardioverter defibrillator in clinical practice.
    Chung MK
    Cardiol Clin; 2014 May; 32(2):253-70. PubMed ID: 24793801
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Defibrillation for Ventricular Fibrillation: A Shocking Update.
    Nichol G; Sayre MR; Guerra F; Poole J
    J Am Coll Cardiol; 2017 Sep; 70(12):1496-1509. PubMed ID: 28911514
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Are MADIT II criteria for implantable cardioverter defibrillator implantation appropriate for Chinese patients?
    Siu CW; Pong V; Ho HH; Liu S; Lau CP; Li SW; Tse HF
    J Cardiovasc Electrophysiol; 2010 Mar; 21(3):231-5. PubMed ID: 19804551
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Distance to invasive heart centre, performance of acute coronary angiography, and angioplasty and associated outcome in out-of-hospital cardiac arrest: a nationwide study.
    Tranberg T; Lippert FK; Christensen EF; Stengaard C; Hjort J; Lassen JF; Petersen F; Jensen JS; Bäck C; Jensen LO; Ravkilde J; Bøtker HE; Terkelsen CJ
    Eur Heart J; 2017 Jun; 38(21):1645-1652. PubMed ID: 28369362
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The association between alcohol intake shortly before arrest and survival outcomes of out-of-hospital cardiac arrest.
    Choi DH; Ro YS; Kim KH; Park JH; Jeong J; Hong KJ; Song KJ; Shin SD
    Resuscitation; 2022 Apr; 173():39-46. PubMed ID: 35151774
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-Term Post-Discharge Risks in Older Survivors of Myocardial Infarction With and Without Out-of-Hospital Cardiac Arrest.
    Fordyce CB; Wang TY; Chen AY; Thomas L; Granger CB; Scirica BM; Henry TD; Wong GC; Ramanathan K; Hansen CM; Kragholm K; Peterson ED; Anderson ML
    J Am Coll Cardiol; 2016 May; 67(17):1981-90. PubMed ID: 27126525
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment and outcomes of ST segment elevation myocardial infarction and out-of-hospital cardiac arrest in a regionalized system of care based on presence or absence of initial shockable cardiac arrest rhythm.
    Thomas JL; Bosson N; Kaji AH; Ji Y; Sung G; Shavelle DM; French WJ; Koenig W; Niemann JT
    Am J Cardiol; 2014 Oct; 114(7):968-71. PubMed ID: 25118120
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials.
    Hess PL; Laird A; Edwards R; Bardy GH; Bigger JT; Buxton AE; Moss AJ; Lee KL; Hall WJ; Steinman R; Dorian P; Hallstrom A; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Al-Khatib SM; Piccini JP; Inoue LY; Sanders GD
    Heart Rhythm; 2013 Jun; 10(6):828-35. PubMed ID: 23416381
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recurrent ventricular arrhythmias and mortality in cardiac arrest survivors with a reversible cause with and without an implantable cardioverter defibrillator: A systematic review.
    van der Lingen ACJ; Woudstra J; Becker MAJ; Mol MAE; van Rossum AC; Rijnierse MT; Allaart CP
    Resuscitation; 2022 Apr; 173():76-90. PubMed ID: 35227821
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Effect of Elapsed Time from Myocardial Infarction on Mortality and Major Adverse Cardiac and Cerebrovascular Events in ICD Patients.
    Bons LR; Dabiri-Abkenari L; VAN Domburg RT; Szili-Torok T; Zijlstra F; Theuns DA
    Pacing Clin Electrophysiol; 2015 Dec; 38(12):1448-55. PubMed ID: 26289034
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators.
    Seegers J; Conen D; Jung K; Bergau L; Dorenkamp M; Lüthje L; Sohns C; Sossalla ST; Fischer TH; Hasenfuss G; Friede T; Zabel M
    Europace; 2016 Aug; 18(8):1194-202. PubMed ID: 26622054
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ten-year experience of an invasive cardiology centre with out-of-hospital cardiac arrest patients admitted for urgent coronary angiography.
    Zeliaś A; Stępińska J; Andres J; Trąbka-Zawicki A; Sadowski J; Żmudka K
    Kardiol Pol; 2014; 72(8):687-99. PubMed ID: 24846357
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Patient barriers to implantable cardioverter defibrillator implantation for the primary prevention of sudden cardiac death in patients with heart failure and reduced ejection fraction.
    Chan LL; Lim CP; Aung ST; Quetua P; Ho KL; Chong D; Teo WS; Sim D; Ching CK
    Singapore Med J; 2016 Apr; 57(4):182-7. PubMed ID: 27075476
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Increased risk of ventricular arrhythmias in survivors of out-of-hospital cardiac arrest with chronic total coronary occlusion.
    Yap SC; Sakhi R; Theuns DAMJ; Yasar YE; Bhagwandien RE; Diletti R; Zijlstra F; Szili-Torok T
    Heart Rhythm; 2018 Jan; 15(1):124-129. PubMed ID: 28917556
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.
    Hess PL; Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton A; Cappato R; Dorian P; Hallstrom A; Kadish AH; Kudenchuk PJ; Lee KL; Mark DB; Moss AJ; Steinman R; Inoue LY; Sanders G
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2):179-86. PubMed ID: 25669833
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comorbidity and favorable neurologic outcome after out-of-hospital cardiac arrest in patients of 70 years and older.
    Beesems SG; Blom MT; van der Pas MH; Hulleman M; van de Glind EM; van Munster BC; Tijssen JG; Tan HL; van Delden JJ; Koster RW
    Resuscitation; 2015 Sep; 94():33-9. PubMed ID: 26116780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.